Latest News- Pharmaceutical Contract Packaging Market: Plastic bottles is expected to lead the Packaging segment during 2025-2029

The Pharmaceutical Contract Packaging Market is being driven by Rising research and development spending in pharmaceutical industry

The Pharmaceutical Contract Packaging Market is expected to grow at a CAGR of 16.5% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 10437 million. The pharmaceutical industry faces increasing competition due to the impending patent expirations of several blockbuster drugs between 2024 and 2026. Over 40 major drugs, including high-revenue products like Ticagrelor (Brilinta) and Entresto (sacubitril/valsartan), are set to lose exclusivity in 2025. This trend will result in the entry of affordable generic and biosimilar alternatives, intensifying competition and potentially reducing profit margins for original brand-name producers. Pharmaceutical manufacturers face challenges in investing in research and development for innovative and customized packaging solutions due to these market dynamics. 

Get more information on Pharmaceutical Contract Packaging Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Packaging
  • Plastic bottles
  • Blister packs
  • Pouches
  • Parenteral containers
  • Pre-filled syringes
• Type
  • Primary
  • Secondary
  • Tertiary
• Industry Application
  • Small molecule pharmaceuticals
  • Biopharmaceuticals
  • Vaccines
• Geography
  • North America
    • Canada
    • US
  • APAC
    • China
    • India
    • Japan
    • South Korea
  • Europe
    • Germany
    • UK
    • France
  • Middle East and Africa
  • South America
    • Brazil

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Rising research and development spending in pharmaceutical industry
• Growing global pharmaceutical sales
• Increasing number of new drugs approval by FDA

However, the market also witnesses some limitations, which are as follows:

• High cost of anti-counterfeit packaging technology
• Emergence of in-house packaging
• Stringent regulations for pharmaceutical packaging

Benefits of Buying Global Pharmaceutical Contract Packaging Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Pharmaceutical Contract Packaging Market Research Report

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The Pharmaceutical Contract Packaging Market is witnessing significant advancements with the integration of technologies such as e-commerce fulfillment, personalized packaging, and smart packaging featuring RFID tags. Innovations like digital printing, 3D packaging, and augmented reality packaging enhance brand positioning and sustainability. Packaging design software, simulation, and compliance ensure efficiency, waste reduction, and cost optimization. Security measures include product traceability, counterfeit prevention, and packaging integrity testing. Sustainability initiatives encompass supply chain visibility, process validation, and environmental impact assessments. The market prioritizes quality assurance, sterility assurance, and carbon footprint reduction.

Market Research Overview

In the complex and intricately layered pharmaceutical contract packaging market, various players provide specialized services such as secondary packaging, blister packaging, bottle packaging, and tube packaging. The supply chain encompasses raw material suppliers, who offer metal container raw materials like steel, aluminum, and tin for manufacturing metal containers; glass container raw materials including borosilicate, neutral glass, soda-lime-silica glass, treated soda-lime glass, de-alkalized soda-lime glass, and regular soda-lime glass; and plastic container raw materials such as high-density polyethylene (HDPE), low-density polyethylene (LDPE), polyethylene terephthalate (PET), polypropylene (PP), and polyvinyl chloride (PVC). This diverse range of inputs ensures the production of high-quality, safe, and effective packaging solutions for pharmaceutical products.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/